Lu AA-33810
From Infogalactic: the planetary knowledge core
260px | |
Systematic (IUPAC) name | |
---|---|
N-[(trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl)methyl]methanesulfonamide
|
|
Identifiers | |
ATC code | None |
PubChem | CID: 22254068 |
ChemSpider | 21223462 |
ChEMBL | CHEMBL1836317 |
Synonyms | Lu AA-33810 |
Chemical data | |
Formula | C19H25N3O2S3 |
Molecular mass | 423.615 g/mol |
|
|
|
|
(verify) |
Lu AA-33810 is a drug developed by Lundbeck, which acts as a potent and highly selective antagonist for the Neuropeptide Y receptor Y5, with a Ki of 1.5nM and around 3300x selectivity over the related Y1, Y2 and Y4 receptors. In animal studies it produced anorectic, antidepressant and anxiolytic effects, and further research is now being conducted into its possible medical application in the treatment of eating disorders.[1]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- REDIRECT Template:Peptide receptor modulators
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Neuropeptide Y antagonists
- Nervous system drug stubs